Home » Topics » BioWorld Science

BioWorld Science
RSS

New aminopeptidase N inhibitors and their use in atherosclerosis and other disorders

June 1, 2004

Novel beta2-adrenoceptor agonists discovered at Boehringer Ingelheim

June 1, 2004

Dual PDE3/L-type Ca2+ channel inhibitors covered by Artesian patent

June 1, 2004

Encore claims esters of R-NSAIDs and their therapeutic use

June 1, 2004

Two series of MMP, TACE and/or aggrecanase inhibitors presented by BMS

June 1, 2004

UCB to acquire Celltech

June 1, 2004

Zemplar approved for pediatric use

June 1, 2004

Atiprimod enters new phase I/II trial in relapsed multiple myeloma

June 1, 2004

AEterna Zentaris unveils new name, progress and plans

June 1, 2004

Anadys selects ANA-975 as development candidate for HCV

June 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...